- March 1, 2023
- Posted by: GMI-Co
- Category: Uncategorized
No Comments
Facing pressure to curb diabetes-treatment costs, the company will cut the list prices for its most commonly prescribed insulin and take other steps to make it easier for patients to afford the drugs.